Nasim Ali

Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial

Beatrice Seddon, Sandra J. Strauss, Jeremy Whelan et al. · The Lancet Oncology · 2017 · 527 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial

John Bridgewater, S. Pugh, Tom Maishman et al. · The Lancet Oncology · 2020 · 239 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 ‘CaboGIST’

Patrick Schöffski, Olivier Mir, Bernd Kasper et al. · European Journal of Cancer · 2020 · 67 citations

Medicine, Oncology, Pharmacology +12

The Utility of PEG3350 without Electrolytes for 2-Day Colonoscopy Preparation in Children

Rima Jibaly, Jenny LaChance, Nicolas Lecea et al. · European Journal of Pediatric Surgery · 2011 · 24 citations

Medicine, Child Health, Pediatrics +16

Impact of centralization of services on outcomes in a rare tumour: Retroperitoneal sarcomas

R Kalaiselvan, Abdullah Malik, Ramya Rao et al. · European Journal of Surgical Oncology · 2018 · 23 citations

Medicine, Oncology, Surgery +11